Alves, W. E. F. M., Bonatelli, M., Dufloth, R., Kerr, L. M., Carrara, G. F. A., da Costa, R. F. A., . . . Pinheiro, C. (2019). CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy. BMC Cancer.
Citación estilo ChicagoAlves, Wilson Eduardo Furlan Matos, et al. "CAIX Is a Predictor of Pathological Complete Response and Is Associated With Higher Survival in Locally Advanced Breast Cancer Submitted to Neoadjuvant Chemotherapy." BMC Cancer 2019.
Cita MLAAlves, Wilson Eduardo Furlan Matos, et al. "CAIX Is a Predictor of Pathological Complete Response and Is Associated With Higher Survival in Locally Advanced Breast Cancer Submitted to Neoadjuvant Chemotherapy." BMC Cancer 2019.